The XRCC4 rs1805377 polymorphism is not associated with the risk of cancer: An updated meta-analysis.
Xin-Yuan ZhangXiao-Han WeiBao-Jie WangJun YaoPublished in: The Journal of international medical research (2021)
Through this meta-analysis, we found no association between the rs1805377 polymorphism and cancer occurrence. This may provide useful information for relevant future studies into the etiology of cancer.